Characterization of acute ischemic cerebrovascular disease patients

Caracterización de pacientes con enfermedad cerebrovascular isquémica aguda

Main Article Content

Miguel Arturo Silva
Danny Efraín Sandoval
Juan Pablo Duran

Abstract

Introduction: due to the high mortality rates associated with cerebrovascular disease, knowledge on its clinical characteristics, risk factors, possible causes, time to initial care and treatment is required in order to implement measures to improve detection and treatment. Objective: to characterize adult patients admitted to Hospital de San José of Bogotá diagnosed with ischemic cerebrovascular disease between June 1 2017 and May 31 2018. Methodology: a descriptive cross-sectional study. Patients older than 18 years diagnosed with cerebrovascular disease were included. Relevant data was collected from clinical records and descriptive statistics were used for data analysis. Results: 160 patients were included. The median progression was 9.9 hours, 85% of patients were admitted presenting no alteration of consciousness and mild severity. The median door-to- imaging time was 36 minutes and door-to-thrombolytic therapy 72.5 minutes. Sixty-five percent of patients received neuroimaging within the first hour of admission, endovenous recanalization procedures were conducted in 13%; of cardiac arrhythmias to 96% and of carotid vessels to 93 %; 82.4% received antiplatelet therapy and 76% were able to walk more than 10 meters at dismissal. Discussion and Conclusions: reducing time until initial medical care is required to meet the currently established international guidelines.

Keywords:

Downloads

Download data is not yet available.

Article Details

Author Biographies

Miguel Arturo Silva, Fundación Universitaria de Ciencias de la Salud

Servicio de Neurología, Hospital de San José, Fundación Universitaria de Ciencias de la Salud. Bogotá DC, Colombia

Danny Efraín Sandoval , Fundación Universitaria de Ciencias de la Salud

Neurología, Fundación Universitaria de Ciencias de la Salud. Bogotá DC, Colombia.

Juan Pablo Duran , Fundación Universitaria de Ciencias de la Salud

Neurología, Fundación Universitaria de Ciencias de la Salud. Bogotá DC, Colombia.

References

Organización Mundial de la Salud (OMS). Manual de la OMS para la vigilancia paso a paso de accidentes cerebrovasculares de la OMS: estrategia paso a paso de la OMS para la vigilancia de accidentes cerebrovasculare / enfermedades no Transmisibles y Salud Mental. : Organización Mundial de la Salud; 2005. 1

Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation. 2016;133(4):e38-360.

Pedraza O, Díaz R, Sánchez E, Iragorri A. Guía neurológica 8. Estrategias de prevención secundaria en ataque cerebrovascular (ACV). Colombia: Asociación Colombiana de Neurología; 2012. p. 24.

National Institute of Neurological D, Stroke rt PASSG. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333(24):1581-7. doi: 10.1056/NEJM199512143332401

Wardlaw JM, Murray V, Berge E, del Zoppo GJ. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev. 2014(7):CD000213. doi: 10.1002/14651858.CD000213.pub3

Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2018;49(3):e46-e110. doi: 10.1161/STR.0000000000000158

Chalela JA, Kidwell CS, Nentwich LM, Luby M, Butman JA, Demchuk AM, et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet. 2007;369(9558):293-8. doi: 10.1016/S0140-6736(07)60151-2

Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359(13):1317-29.

Saver JL. Time is brain--quantified. Stroke. 2006;37(1):263-6. doi: 10.1161/01.STR.0000196957.55928.ab

Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010;375(9727):1695-703. doi: 10.1016/S0140-6736(10)60491-6

Goyal M, Menon BK, van Zwam WH, Dippel DW, Mitchell PJ, Demchuk AM, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387(10029):1723-31. doi: 10.1016/S0140-6736(16)00163-X

Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372(1):11-20. doi: 10.1056/NEJMoa1411587

Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015;372(24):2285-95. doi: 10.1056/NEJMoa1415061

Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015;372(24):2296-306. doi: 10.1056/NEJMoa1503780

Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372(11):1009-18. doi: 10.1056/NEJMoa1414792

Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372(11):1019-30. doi: 10.1056/NEJMoa1414905

Winstein CJ, Stein J, Arena R, Bates B, Cherney LR, Cramer SC, et al. Guidelines for Adult Stroke Rehabilitation and Recovery: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2016;47(6):e98-e169. doi: 10.1161/STR.0000000000000098

Smith EE, Kent DM, Bulsara KR, Leung LY, Lichtman JH, Reeves MJ, et al. Effect of Dysphagia Screening Strategies on Clinical Outcomes After Stroke: A Systematic Review for the 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke. Stroke. 2018;49(3):e123-e8. doi: 10.1161/STR.0000000000000159

Lakshminarayan K, Tsai AW, Tong X, Vazquez G, Peacock JM, George MG, et al. Utility of dysphagia screening results in predicting poststroke pneumonia. Stroke. 2010;41(12):2849-54. doi: 10.1161/STROKEAHA.110.597039

Donovan NJ, Daniels SK, Edmiaston J, Weinhardt J, Summers D, Mitchell PH, et al. Dysphagia screening: state of the art: invitational conference proceeding from the State-of-the-Art Nursing Symposium, International Stroke Conference 2012. Stroke. 2013;44(4):e24-31. doi: 10.1161/STR.0b013e3182877f57

Xie M, Shan Z, Zhang Y, Chen S, Yang W, Bao W, et al. Aspirin for primary prevention of cardiovascular events: meta-analysis of randomized controlled trials and subgroup analysis by sex and diabetes status. PLoS One. 2014;9(10):e90286. doi: 10.1371/journal.pone.0090286

Alvarez LR, Balibrea JM, Surinach JM, Coll R, Pascual MT, Toril J, et al. Smoking cessation and outcome in stable outpatients with coronary, cerebrovascular, or peripheral artery disease. Eur J Prev Cardiol. 2013;20(3):486-95. doi: 10.1177/1741826711426090

Citado por